24. OUTCOMES OF CONGENITAL HEART DEFECT TREATMENT USING INTERVENTIONAL CARDIOLOGY AT CHILDREN'S HOSPITAL 2 FROM 2018 TO 2023

Nguyen Thi Ngoc Phuong, Trinh Huu Tung, Tran Thi Kim hue, Phan Dai Bang, Pham Thi Ngoc Hue

Main Article Content

Abstract

Objectives: A study on the characteristics and outcomes of transcatheter interventions in children with congenital heart defects at Children's Hospital 2 from 2018 to 2023.


Methods: A retrospective cross-sectional descriptive study was conducted based on medical records of inpatient CHD cases over a 6-year period. Epidemiological indicators, types of CHD, interventions, and treatment outcomes were analyzed by year.


Results: From January 2018 to December 2023, we performed catheter-based interventions on 2,667,000 cases of congenital heart disease. Of these, 18.4% were admitted through the emergency department. The mean age was 14.5 ± 24.3 months. Congenital heart defects with left-to-right shunts accounted for the highest proportion (53.6%). Temporary transcatheter interventions represented 34.1% of total cases, with ductal stenting being the most common procedure (69%). The overall success rate of interventional procedures in our study was 93.7%. Age and weight were identified as two significant factors associated with the risk of complications.


Conclusions: Transcatheter intervention is a safe and effective treatment method for various types of congenital heart defects, particularly simple lesions such as patent ductus arteriosus, atrial septal defect, and pulmonary valve stenosis. Despite technical challenges in younger and lower-weight patients, treatment outcomes have significantly improved over time thanks to accumulated experience and advancements in technique.

Article Details

References

[1] Control CfD, Prevention, Control CfD (2019). Accessed PJCDCPhwcgnhdh. Data and statistics on congenital heart defects;30
[2] Heron M (2021). Deaths: Leading causes for 2019.National Vital Statistics Reports, Volume 70, Number 9.
[3] Alakhfash AA, Jelly A, Almesned A, et al.(2020). Cardiac catheterisation interventions in neonates and infants less than three months;32(2):149.
[4] Nguyễn Thị Tuyết Lan, Đỗ Minh Hùng, Nguyễn Thanh Liêm (2022). Đặc điểm lâm sàng và tình hình điều trị bệnh tim bẩm sinh tại Bệnh viện Nhi Trung ương năm 2018-2022. Tạp chí Y học Việt Nam;518:155-161.
[5] Nguyễn Lân Hiếu (2023). Phát triển tim mạch can thiệp nhi khoa tại Việt Nam: Thực trạng và giải pháp. Tạp chí Tim mạch học Việt Nam;58(1):22-29.
[6] Liu L, Wang X, Liu X, et al. (2019). Prevalence of congenital heart disease in the high-altitude regions of China: a systematic review and meta-analysis. Medicine;98(37):e17247.
[7] Boston Children's Hospital (2022). Department of Cardiac Surgery. Annual Report on Congenital Heart Disease. Boston.
[8] Ratnayaka K, Nageotte S, Moore J, et al (2018). Patent ductus arteriosus stenting for all ductal-dependent cyanotic infants: waning use of blalock-taussig shunts. Catheter Cardiovasc Interv;92(7):1301-1309.
[9] Ali F, Yeh MJ, Bergersen L, et al. (2023). Congenital cardiac catheterization in low-and middle-income countries: the international quality improvement collaborative catheterization registry. Cardiol Young;2(4):100344.
[10] Mbabazi N, Aliku T, Namuyonga J, et al. (2024). Congenital heart disease cardiac catheterization at Uganda Heart Institute, a 12-year retrospective study of immediate outcomes. BMC Cardiovasc Disord;24(1):1-12